G&E Herbal Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 07, 2023 at 04:47 pm EDT
Share
G&E Herbal Biotechnology Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 44.49 million compared to TWD 7.65 million a year ago. Net income was TWD 16.69 million compared to net loss of TWD 2.91 million a year ago. Basic earnings per share from continuing operations was TWD 0.3 compared to basic loss per share from continuing operations of TWD 0.05 a year ago. Diluted earnings per share from continuing operations was TWD 0.3 compared to diluted loss per share from continuing operations of TWD 0.05 a year ago.
For the six months, sales was TWD 85.25 million compared to TWD 14.9 million a year ago. Net income was TWD 31.75 million compared to net loss of TWD 7.92 million a year ago. Basic earnings per share from continuing operations was TWD 0.57 compared to basic loss per share from continuing operations of TWD 0.14 a year ago. Diluted earnings per share from continuing operations was TWD 0.57 compared to diluted loss per share from continuing operations of TWD 0.14 a year ago.
G&E Herbal Biotechnology Co., Ltd is a Taiwan-based company principally engaged in the research and development, manufacture and distribution of health care food products, functional skin care products and pharmaceutical products. Its health care food products include accessory food products and capsules for cancer and urogenital disorder. The Company also provides botanical medicines for cancers and liver diseases. The Company distributes its products within domestic market and to overseas markets.
G&E HERBAL BIOTECHNOLOGY CO., LTD. 
